After firing indicted CEO, company now fights to keep shares listed on NASDAQ.
Source: Martin Shkreli’s other pharma company files for bankruptcy | Ars Technica
After firing indicted CEO, company now fights to keep shares listed on NASDAQ.
Source: Martin Shkreli’s other pharma company files for bankruptcy | Ars Technica